We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
MiMedx is suing wound-treatment competitor Osiris Therapeutics, accusing it of falsely claiming in a press release that its biologic is superior to MiMedx’s product. Read More
Amgen is suing generics maker Sandoz, claiming that Sandoz’s attempts to market a biosimilar for the blockbuster bone marrow drug Neulasta infringes on two of its patents for the drug. Read More